Migliavacca, M., Barzaghi, F., Fossati, C., Rancoita, P. M. V., Gabaldo, M., Dionisio, F., . . . Cicalese, M. P. (2024). Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. Nature Medicine, 30(2), 488. https://doi.org/10.1038/s41591-023-02789-4
Chicago-referens (17:e uppl.)Migliavacca, Maddalena, et al. "Long-term and Real-world Safety and Efficacy of Retroviral Gene Therapy for Adenosine Deaminase Deficiency." Nature Medicine 30, no. 2 (2024): 488. https://doi.org/10.1038/s41591-023-02789-4.
MLA-referens (9:e uppl.)Migliavacca, Maddalena, et al. "Long-term and Real-world Safety and Efficacy of Retroviral Gene Therapy for Adenosine Deaminase Deficiency." Nature Medicine, vol. 30, no. 2, 2024, p. 488, https://doi.org/10.1038/s41591-023-02789-4.
